Gene mutation increases drug toxicity, rejection risk in pediatric kidney transplants
Wednesday, February 18, 2009 - 09:50
in Health & Medicine
Screening for mutations in a gene that helps the body metabolize a kidney transplant anti-rejection drug may predict which children are at higher risk for side effects, including compromised white blood cell count or organ rejection, according to new research.
Read the whole article on Physorg
More from Physorg
Related
- Gene mutation increases drug toxicity, rejection risk in pediatric kidney transplantsWed, 18 Feb 2009, 9:56:22 EST
- Anti-rejection drug may increase risk of diabetes after kidney transplantThu, 22 May 2008, 14:22:04 EDT
- Drug may prolong organ life in noncompliant kidney transplant patientsSat, 31 May 2008, 3:42:36 EDT
- Affordable anti-rejection drug as effective as higher cost optionWed, 14 Oct 2009, 12:43:53 EDT
- Study points to 1 cause of higher rates of transplanted kidney rejection in blacksFri, 29 Aug 2008, 16:14:29 EDT